Xenpozyme (olipudase alfa)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xenpozyme (olipudase alfa), covering 2025-02-06 to 2025-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France